Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer

Fig. 6

Mice were divided into eight groups as follows: (1) PBS as a control, (2) MoS2-PEG-Biotin, (3) Cur, (4) Er, (5) Cur + Er, (6) MoS2-PEG-Biotin + NIR, (7) MoS2-PEG-Biotin-Cur/Er, and (8) MoS2-PEG-Biotin-Cur/Er + NIR, a Tissue biodistribution of Mo2+ measured by ICP-MS after intravenous administration of MoS2-PEG-Biotin-Cur/Er and MoS2-PEG-Cur/Er as a function of time. b Temperature changes of tumors during NIR irradiation. c Thermal images of tumor-bearing mice in (b). d The tumor growth curve of all groups during 21-day treatments. Significant differences between the MoS2-PEG-Biotin-Cur/Er + NIR group and the other groups are indicated as **p < 0.01. e The tumor growth inhibition ratio of the experimental groups. Significant differences between the MoS2-PEG-Biotin-Cur/Er + NIR group and the other groups are indicated as **p < 0.01. f Photographs of tumors from each group after 21 days. g HE images of tumors from each group

Back to article page